This updated article clarifies the nature of Karl Voelkerding's new relationship with EraGen. The researcher was appointed, not hired, by the company.

NEW YORK, Aug. 7 - EraGen Biosciences on Tuesday said it had appointed clinical pathologist Karl Voelkerding to serve on its scientific board.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new study suggests CRISPR could be used to save coral reefs from dying off, Forbes reports.

Researchers have found that the i-motif shape of DNA previously observed in the lab also exists in human cells, and that it may serve a purpose.

In PNAS this week: a genomic, transcriptomic, and metabolomic analysis of the tea plant, Arabidopsis thaliana's adaptations to specific local environments, and more.

In an against-all-odds twist, a researcher studying exceeding rare FOXG1 mutations discovers her daughter has the syndrome.